Fact checked byGina Brockenbrough, MA

Read more

December 08, 2024
1 min read
Save

Maxx Orthopedics announces FDA clearance of medial congruent insert for TKA system

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Maxx Orthopedics announced FDA clearance of a medial congruent insert for its Freedom total knee system.
  • The insert is designed to provide medial stability and replicate kinematics of the natural knee.

Maxx Orthopedics Inc. announced it received FDA clearance of a medial congruent insert for its Freedom total knee arthroplasty system, according to a press release.

The Freedom medial congruent insert is designed to match natural knee mechanics and improve medial stability for patients undergoing TKA, according to the release.

Generic FDA News infographic
Maxx Orthopedics announced FDA clearance of a medial congruent insert for its Freedom total knee system.

“The Freedom medial congruent insert reflects Maxx Orthopedics' commitment to continuous innovation,” Ashesh Shah, CEO of Maxx Orthopedics, said in the release. “The Freedom medial congruent insert expands the Freedom knee portfolio by providing a tibial insert designed to give patients knee movement, in cruciate-retaining procedures, that mimics the natural knee.”